Influenza B virus neuraminidase: a potential target for next-generation vaccines?-Reference-Cited by-同舟云学术

Influenza B virus neuraminidase: a potential target for next-generation vaccines?

Published:2023-12-14 Issue:1 Volume:23 Page:39-48
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Do Thi Hoai Thu¹,Wheatley Adam K.¹,Kent Stephen J.¹²,Koutsakos Marios¹

Affiliation:

1. Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute of Infection and Immunity, Melbourne, Australia

2. Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Australia

Funder

Morningside Foundation

National Health and Medical Research Council

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2023.2290691

Reference66 articles.

1. Influenza A virus hemagglutinin specific antibodies interfere with virion neuraminidase activity via two distinct mechanisms

2. Innate and adaptive immunity toward influenza B viruses

3. Knowns and unknowns of influenza B viruses

4. The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century

5. Differential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Citrus-derived flavanones as neuraminidase inhibitors: In vitro and in silico study;European Journal of Medicinal Chemistry;2024-11

2. Genomic evolution of influenza during the 2023–2024 season, the johns hopkins health system;Journal of Clinical Virology;2024-10

3. Influenza B Virus Vaccine Innovation through Computational Design;Pathogens;2024-09-02

4. Triton-X 100-treated virus-based ELLA demonstrates discordant antigenic evolution of influenza B virus haemagglutinin and neuraminidase;2024-07-09

5. Cellular and Molecular Immunity to Influenza Viruses and Vaccines;Vaccines;2024-04-07